Trial intelligence / Profile preview

CPL-01 in Postoperative Pain After Open Inguinal Herniorrhaphy

NCT05080959Phase 2Completed

Sponsor
Cali Pharmaceuticals
Start
Jul 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of CPL-01 in postoperative pain, sponsored by Cali Pharmaceuticals. Started Jul 2021; status: completed.

02

Drugs

CPL-01
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05080959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05080959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call